Glycans in Diseases and Therapeutics

Glycomedicine functions as essential role in cell-cell adhesion i.e. a device used by cells of the immune system through sugar-binding proteins called lectins, which classify precise carbohydrate portions. Glycans (carbohydrate oligomers) are the so-called “building blocks” of carbohydrates, nucleic acids, proteins and lipids play leading roles in various biological phenomena as well as in numerous pathophysiological procedures. Several scientists have now understood that glycosylation, i.e. the count of glycans to a protein backbone, is the most plentiful post translational alteration responses and is a major field of research and sometimes they require a glycobiology method to be exploited

    Related Conference of Glycans in Diseases and Therapeutics

    January 22-23, 2026

    26th World Congress on Medicinal Chemistry and Drug Design

    Bangkok, Thailand
    February 25-26, 2026

    16th International Conference on Chemistry Meeting

    Paris, France
    February 26-27, 2026

    29th World Congress on Materials Chemistry

    Paris, France
    June 17-18, 2026

    15th World Congress on Chromatography

    Paris, France
    August 11-12, 2026

    5th World Congress on Plasma Chemistry and Plasma Processing

    Amsterdam, Netherlands
    September 21-22, 2026

    16th International Chemistry Congress

    Barcelona, Spain
    November 26-27, 2026

    6th International Conference on Petrochemistry and Natural Gas

    Amsterdam, Netherlands

    Glycans in Diseases and Therapeutics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in